Cargando…
The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer
There is clinical and experimental evidence suggesting that antiprogestins might be used for the treatment of selected breast cancer patients. Our aim was to evaluate the effect of albumin-bound paclitaxel (Nab-paclitaxel) and pegylated doxorubicin liposomes (PEG-LD) in combination with mifepristone...
Autores principales: | Sequeira, Gonzalo, Vanzulli, Silvia I, Rojas, Paola, Lamb, Caroline, Colombo, Lucas, May, María, Molinolo, Alfredo, Lanari, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102807/ https://www.ncbi.nlm.nih.gov/pubmed/24912774 |
Ejemplares similares
-
Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
por: Elía, Andrés, et al.
Publicado: (2023) -
Inoculated mammary carcinoma-associated fibroblasts: contribution to hormone independent tumor growth
por: Fabris, Victoria T, et al.
Publicado: (2010) -
Isoform specificity of progesterone receptor antibodies
por: Fabris, Victoria, et al.
Publicado: (2017) -
Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice
por: Lamb, Caroline A, et al.
Publicado: (2005) -
Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)